Article
Four novel mutations identification in 17 beta-hydroxysteroid dehydrogenase-3 deficiency and our clinical experience: possible benefits of early treatment.
Frontiers in endocrinology - 1 Jan 2023
Wang Yunpeng, Xu Yu, Zhang Huijiao, Yin Danyang, Pan Yiming, He Xiwen, Li Shuaiting, Cheng Zhi, Zhu Gaohui, Zhao Ting, Huang Huizhe, Zhu Min
Abstract excerpt
Introduction: Individuals with 17-beta-hydroxysteroid dehydrogenase type 3 (17β-HSD3) deficiency face a multitude of challenges, primarily concerning genital appearance, potential malignancy risks, and fertility issues. This study reports our findings from an investigation involving five individuals affected by 17β-HSD3 deficiency, ranging in age from pre-adolescence to adolescence. Notably, we identified four...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
